Author Verbeek, Marcel M.
-
2003 | Journal Article
Quality assurance for cerebrospinal fluid protein analysis: International consensus by an Internet-based group discussion
Reiber, H.; Thompson, E. J.; Grimsley, G.; Bernardi, G.; Adam, P.; de Almeida, S. F. M. & Fredman, P. et al. (2003)
Clinical Chemistry and Laboratory Medicine (CCLM), 41(3) pp. 331-337. DOI: https://doi.org/10.1515/CCLM.2003.053
Details DOI PMID PMC WoS
-
2012 | Review
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al. (2012)
Biomarkers in Medicine, 6(4) pp. 419-430.
Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46
Details DOI PMID PMC WoS
-
2015 | Journal Article |
A practical guide to immunoassay method validation
Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 179. DOI: https://doi.org/10.3389/fneur.2015.00179
Details DOI PMID PMC WoS
-
2015 | Journal Article
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Kruse, N.; Persson, S.; Alcolea, D.; Bahl, J. M. C.; Baldeiras, I.; Capello, E. & Chiasserini, D. et al. (2015)
Neurobiology of Aging, 36(9) pp. 2587-2596. DOI: https://doi.org/10.1016/j.neurobiolaging.2015.05.003
Details DOI PMID PMC WoS
-
2015 | Review
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
Laurens, B.; Constantinescu, R.; Freeman, R.; Gerhard, A.; Jellinger, K.; Jeromin, A.& Krismer, F. et al. (2015)
Neurobiology of Disease, 80 pp. 29-41.
Academic Press Inc Elsevier Science. DOI: https://doi.org/10.1016/j.nbd.2015.05.004
Details DOI PMID PMC WoS
-
2015 | Journal Article |
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 216. DOI: https://doi.org/10.3389/fneur.2015.00216
Details DOI PMID PMC WoS
-
2016 | Journal Article
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al. (2016)
Journal of Alzheimer's Disease, 52(1) pp. 51-64. DOI: https://doi.org/10.3233/jad-150883
Details DOI
-
2016 | Review
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Mollenhauer, B.; Parnetti, L.; Rektorova, I.; Kramberger, M. G.; Pikkarainen, M.; Schulz-Schaeffer, W. J.& Aarsland, D. et al. (2016)
Journal of Neurochemistry, 139 pp. 290-317.
Wiley-blackwell. DOI: https://doi.org/10.1111/jnc.13390
Details DOI PMID PMC WoS
-
2016 | Journal Article
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Simonsen, A. H.; Kuiperij, B.; El-Agnaf, O. M. A.; Engelborghs, S.; Herukka, S.-K.; Parnetti, L. & Rektorova, I. et al. (2016)
Biomarkers in Medicine, 10(1) pp. 19-34. DOI: https://doi.org/10.2217/BMM.14.105
Details DOI PMID PMC WoS
-
2016 | Journal Article
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases
van Waalwijk van Doorn, L. J. C.; Koel-Simmelink, M. J.; Haußmann, U.; Klafki, H. ; Struyfs, H.; Linning, P. & Knölker, H.-J. et al. (2016)
Journal of Neurochemistry, 137(1) pp. 112-121. DOI: https://doi.org/10.1111/jnc.13527
Details DOI PMID PMC
-
2018 | Journal Article
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al. (2018)
The World Journal of Biological Psychiatry, 19(4) pp. 244-328. DOI: https://doi.org/10.1080/15622975.2017.1375556
Details DOI
-
2018 | Journal Article
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson, N.; Groot, C.; Jansen, W. J.; Landau, S. M.; Villemagne, V. L.; Engelborghs, S. & Mintun, M. M. et al. (2018)
Alzheimer's & Dementia, 14(7) pp. 913-924. DOI: https://doi.org/10.1016/j.jalz.2018.02.009
Details DOI
-
2018 | Journal Article |
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P. & Lleó, A. et al. (2018)
Alzheimer's Research & Therapy, 10(1). DOI: https://doi.org/10.1186/s13195-018-0359-x
Details DOI
-
2021 | Journal Article |
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
van Rumund, A.; Pavelka, L.; Esselink, R. A. J.; Geurtz, B. P. M.; Wevers, R. A.; Mollenhauer, B. & Krüger, R. et al. (2021)
npj Parkinson's Disease, 7(1). DOI: https://doi.org/10.1038/s41531-021-00172-z
Details DOI
-
2022 | Journal Article | Research Paper
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Oeckl, P.; Anderl-Straub, S.; Von Arnim, C. A. F.; Baldeiras, I.; Diehl-Schmid, J.; Grimmer, T. & Halbgebauer, S. et al. (2022)
Journal of Neurology, Neurosurgery & Psychiatry,. DOI: https://doi.org/10.1136/jnnp-2021-328547
Details DOI PMID PMC